W

Waterdrop Inc
F:717

Watchlist Manager
Waterdrop Inc
F:717
Watchlist
Price: 1.19 EUR Market Closed
Market Cap: €439m

Waterdrop Inc
Investor Relations

Waterdrop Inc. is a Chinese internet company that helps people buy insurance and pay for medical care. Its main business is an online insurance marketplace where it matches consumers with policies from insurers and earns fees when a policy is sold. It also has a medical crowdfunding service that lets patients raise money for serious treatment from individual donors. The company mainly serves everyday consumers in China, especially people looking for affordable health, life, and accident coverage or help with large medical bills. It makes money from commissions and service fees tied to insurance sales, as well as fees from related healthcare and technology services. Its business sits between insurers, hospitals, patients, and donors, which gives it a role as a digital middleman in personal protection and medical financing. What makes Waterdrop different is that it is not an insurer itself. It does not underwrite the policies or carry most of the insurance risk; instead, it uses its platform, data, and customer traffic to connect users with third-party products and services. That makes its success depend on how well it can attract users, convert them into customers for partners, and keep trust in a sensitive area like health and medical finance.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Mar 25, 2026
AI Summary
Q4 2025

Revenue: Full-year revenue RMB 3.98 billion, up 43.5% YoY; Q4 revenue RMB 1.41 billion, up 105.5% YoY.

Profitability: Net profit attributable to ordinary shareholders RMB 570 million for FY2025 (management reported YoY growth of 64.8% in prepared remarks; finance slide later cited 54.8%), and company has delivered GAAP profitability for 16 consecutive quarters.

Insurance Momentum: Insurance-related income for FY2025 about RMB 3.58 billion, up 51.3% YoY; Q4 insurance-related income RMB 1.31 billion, up 125% YoY; Q4 insurance operating profit RMB 160 million, up 42% YoY.

AI Integration: Management emphasized an "AI-native" shift — Waterdrop Sea.AI platform, multi-modal agents, 72 LLM-related patent filings, and operational AI agents across acquisition, sales, customer service and R&D.

Capital Returns: Board approved cash dividend of $0.03 per ADS (total $10.8 million) and ongoing share repurchase program (60.7 million ADS repurchased for about $118 million by end of 2026, per prepared remarks).

Medical & Trials: Medical crowdfunding cumulative donors ~490 million, RMB 72.3 billion donated to 3.68 million patients; digital clinical trial sourcing revenue RMB 118 million and record enrollments with over 4,000 patients for trials this year.

Cost & Investment: Q4 operating costs RMB 680 million (up 109.2% YoY); quarterly operating costs and expenses RMB 1.33 billion (up 109.4% YoY); sales & marketing scaled to ~RMB 510 million (up 178.4% YoY) as company increases marketing and AI investments.

Key Financials
Revenue (full year)
RMB 3.98 billion
Revenue (Q4)
RMB 1.41 billion
Net profit attributable to ordinary shareholders (full year)
RMB 570 million
Insurance-related income (full year)
RMB 3.58 billion
Insurance-related income (Q4)
RMB 1.31 billion
Insurance operating profit (Q4)
RMB 160 million
Operating costs (Q4)
RMB 680 million
Operating costs and expenses (Q4)
RMB 1.33 billion
Sales and marketing expenses (Q4)
RMB 510 million (roughly)
Research and development expenses (Q4)
RMB 66.2 million (approximately)
Cash position
RMB 3.25 billion
Medical crowdfunding cumulative donors
approximately 490 million people
Total donations (cumulative)
RMB 72.3 billion
Patients helped (cumulative)
3.68 million patients
Digital clinical trial sourcing revenue
RMB 118 million
Digital clinical trial enrollments (this year)
over 4,000 patients
Dividend per ADS
$0.03 per ADS
Share repurchase (program status cited)
60.7 million ADS repurchased for about $118 million (by end of 2026, per remarks)
InterTech / platform patient responses
platform responded for 3.68 million patients since launch (as cited in CEO remarks)
Earnings Call Recording
Other Earnings Calls

Management

Dr. Peng Shen
Co-Founder, Chairman of the Board & CEO
No Bio Available
Mr. Guang Yang
Co-Founder, VP of Finance, GM of International Business & Director
No Bio Available
Ms. Xiaoying Xu
Head of Finance
No Bio Available
Mr. Xiaojiao Cui
Investor Relations Officer
No Bio Available
Ms. Nian Liu
Head of Legal
No Bio Available
Ms. Xiaolei Sun
Vice President of Human Resources & Organization Development
No Bio Available
Mr. Wei Ran
Partner, GM of Insurance Technology Business & Director
No Bio Available
Mr. Xiaobo Zhou
Head of Research & Development
No Bio Available

Contacts

Address
BEIJING
Beijing
Block C, Wangjing Science Park, No. 2 Lize Zhonger Road, Chaoyang
Contacts
+861053394997.0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett